STSA-1002 Injection: Clinical Trials

1 trial of STSA-1002 Injection, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

1 completed. 1 Phase 1, 1 Phase 2.

By phase and status

PhaseTrialsStatus
Phase 11Completed 1
Phase 21Completed 1

Follow STSA-1002 Injection: new trials by email Literature Review of STSA-1002 Injection trials Research Report on STSA-1002 Injection

Trials (filtered) newest first · largest first

All 1 trial

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
To Evaluate The Safety and Initial Efficacy of STSA-1002 Injection in Patients With Acute Respiratory Distress Syndrome
STSA-1002 Injection Placebo, STSA-1002 Injection - Acute Respiratory Distress Syndrome
Phase 1 / Phase 2CompletedStaidson (Beijing) Biopharmaceuticals Co., Ltd472023-12-092025-07-11

Conditions studied

Respiratory Distress Syndrome (1)

Sponsors

Staidson (Beijing) Biopharmaceuticals Co., Ltd (1)

Countries

China (1)

Top investigators

Bin Cao, Ph.D (1)

Results publications

PMID 42142803